Statistics
The Kailera Therapeutics stock price is currently $ 13.27 with a total market cap valuation of $ 1.72B (129.85M shares outstanding). The Kailera Therapeutics is trading on NASDAQ under the ticker sign KLRA. Kailera Therapeutics price is up
Description
Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Company Profile
- Full Name: Kailera Therapeutics
- Sector: Healthcare
- Website: www.kailera.com
